USPTO 2015–2025 USPTO PatentsView Foreign Corporation

MolecuLight Inc.

USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Moleculight ranks #24,822 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.

#24,822
of 49,997 US assignees by volume
22nd percentile
by Innovation Score (27.1/100)
11.6
avg claims per patent
+800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24822 · Foreign Corporation #24,822 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,822/49,997
  • PHOTO-FINISH Mobile Heartbeat
  • CPC-NARROW A61B · 6 areas
  • INNOV-THIN 27.1/100
  • CLAIMS-PAR 11.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +800% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mobile Heartbeat, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Moleculight’s 27.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Moleculight

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Moleculight's Innovation Score is 27.1/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Moleculight?

Each dot is one of Moleculight’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Moleculight’s own 11.6 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Moleculight vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 0102030 Granted patents (volume) Avg claims / patent Mobile Heartbeat, LLC - 11, 23.27Mobile HeartbeatMocktail Beverages Inc. - 11, 5.73Mocktail BeveragesModelOp, Inc. - 11, 19.91ModelopModology Design Group - 11, 16.45Modology Design G…Mountain Blue Orchards PTY Ltd - 11, 1Mountain Blue Orc…Multitest Elektronische Systeme GmbH - 11, 10.91Multitest Elektro…MyPinPad Limited - 11, 24MypinpadMyoKardia, Inc. - 11, 25.45MyokardiaMolecuLight Inc. - 11, 11.64Moleculight
Moleculight vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Moleculight's grants concentrate

MolecuLight Inc. is a focused PatentsView assignee: 6 CPC subclasses with 18.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2019. By volume, Moleculight sits between Mobile Heartbeat, LLC and MyoKardia, Inc..

Moleculight's three-year grant acceleration

MolecuLight Inc. shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at MolecuLight's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows MolecuLight holds 11 patents at rank #24,820, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near MolecuLight

By rank, the assignees closest to #24,820 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in MolecuLight's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for MolecuLight, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), MolecuLight ranks #4,824 of 7,127 assignees by patent count in that subclass.

Moleculight's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201920202021202220232025 1
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
MolecuLight Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 9.1%
2020 4 36.4%
2021 2 18.2%
2022 2 18.2%
2023 1 9.1%
2025partial year 1 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

MolecuLight Inc.'s patent record in context - here's where to go next.

  • MolecuLight Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 18.2% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #24,822 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare MolecuLight Inc. against Mobile Heartbeat, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.